Compound Detail
CHEMBL2070710
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL2070710 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZNFAHBOXDSESRQ-PPHPATTJSA-N |
| Parent Compound | CHEMBL2079179 |
| Active Moiety | CHEMBL2079179 |
1
Targets
3
Activities
2
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
380.4
MW (Da)
2.67
ALogP
4
HBA
4
HBD
96.2
PSA (Ų)
0.66
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 2 meas. best 7.7
IC50 1 meas. best 7.52
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Serine/threonine-protein kinase Chk1 CHEMBL4630 | EC50 | 7.7 | 6.83 | 20.0 | 2 |
| Serine/threonine-protein kinase Chk1 CHEMBL4630 | IC50 | 7.52 | 7.52 | 30.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Serine/threonine-protein kinase Chk1 | EC50 | = | 20.0 | nM | 7.7 | Inhibition of CHK1 in human HT29 cells assessed as abrogation of camptothecin in... | 22551018 |
| Serine/threonine-protein kinase Chk1 | IC50 | = | 30.0 | nM | 7.52 | Inhibition of human recombinant CHK1 expressed in insect cells using biotinylami... | 22551018 |
| Serine/threonine-protein kinase Chk1 | EC50 | = | 1100.0 | nM | 5.96 | Inhibition of CHK1 in human HT29 cells assessed as check point abrogation | 22551018 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22551018 | 10.1021/jm300025r | Serine/threonine-protein kinase Chk1 | 3 |
Data from ChEMBL 36 via Core Engine